多发性骨髓瘤的长期存活:一个意大利的经验
Francesca Fazio1, Martina Gherardini1, Elena Rossi2
1Hematology Department of Translational and Precision Medicine, Sapienza University Azienda Policlinico Umberto I, 00185 Rome, Italy.
Cancers
|February 13, 2025
概括
这项研究分析了长期多发性骨髓瘤 (MM) 幸存者,发现年龄较大,低白蛋白和多种疗法预测了更短的生存期. 为了更好的患者分层和有针对性的治疗,需要进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床医学 临床医学
背景情况:
- 多发性骨髓瘤 (MM) 治疗得到了改善,新诊断患者 (NDMM) 的平均整体存活期 (OS) 延长到6-8年.
- 尽管有进展,但只有大约50%的MM患者能存活5年,28%的患者能存活10年.
- 关于MM患者长期存活的特征的数据有限.
研究的目的:
- 分析10年或更长时间生存的MM患者的临床概况.
- 确定多发性骨髓瘤中长期生存的潜在预测因素.
主要方法:
- 进行了一项多中心的观察性研究.
- 这项研究分析了344名长期多发性骨髓瘤幸存者的队列.
主要成果:
- 该队列的中位数年龄为59岁,诊断后的中位数为13.4岁.
- 60岁以上的年龄,诊断时的低albuminemia,以及接受3次或更多的抗髓瘤疗法是减少OS的独立预后因素.
- 这些因素表明多发性骨髓瘤的长期存活预后较差.
结论:
- 这项研究提供了对长期多发性骨髓瘤幸存者的真实数据.
- 确定减少OS的预测因素对于分层患者至关重要.
- 需要进行前性研究,以确定针对新诊断多发性骨髓瘤的量身定制治疗的生物标志物.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.1K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
5.7K
相关概念视频
Assumptions of Survival Analysis
84
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
84
Comparing the Survival Analysis of Two or More Groups
127
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
127
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
